Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population
- PMID: 7566021
- DOI: 10.1056/NEJM199511163332002
Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population
Abstract
Background: Dietary plant sterols, especially sitostanol, reduce serum cholesterol by inhibiting cholesterol absorption. Soluble sitostanol may be more effective than a less soluble preparation. We tested the tolerability and cholesterol-lowering effect of margarine containing sitostanol ester in a population with mild hypercholesterolemia.
Methods: We conducted a one-year, randomized, double-blind study in 153 randomly selected subjects with mild hypercholesterolemia. Fifty-one consumed margarine without sitostanol ester (the control group), and 102 consumed margarine containing sitostanol ester (1.8 or 2.6 g of sitostanol per day).
Results: The margarine containing sitostanol ester was well tolerated. The mean one-year reduction in serum cholesterol was 10.2 percent in the sitostanol group, as compared with an increase of 0.1 percent in the control group. The difference in the change in serum cholesterol concentration between the two groups was -24 mg per deciliter (95 percent confidence interval, -17 to -32; P < 0.001). The respective reductions in low-density lipoprotein (LDL) cholesterol were 14.1 percent in the sitostanol group and 1.1 percent in the control group. The difference in the change in LDL cholesterol concentration between the two groups was -21 mg per deciliter (95 percent confidence interval, -14 to -29; P < 0.001). Neither serum triglyceride nor high-density lipoprotein cholesterol concentrations were affected by sitostanol. Serum campesterol, a dietary plant sterol whose levels reflect cholesterol absorption, was decreased by 36 percent in the sitostanol group, and the reduction was directly correlated with the reduction in total cholesterol (r = 0.57, P < 0.001).
Conclusions: Substituting sitostanol-ester margarine for part of the daily fat intake in subjects with mild hypercholesterolemia was effective in lowering serum total cholesterol and LDL cholesterol.
Comment in
-
Lowering cholesterol with drugs and diet.N Engl J Med. 1995 Nov 16;333(20):1350-1. doi: 10.1056/NEJM199511163332010. N Engl J Med. 1995. PMID: 7566029 No abstract available.
Similar articles
-
Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.J Lab Clin Med. 2004 Apr;143(4):255-62. doi: 10.1016/j.lab.2003.11.007. J Lab Clin Med. 2004. PMID: 15085084
-
Ratio of lathosterol to campesterol in serum predicts the cholesterol-lowering effect of sitostanol-supplemented margarine.Int J Clin Pharmacol Ther. 2005 Jul;43(7):305-10. doi: 10.5414/cpp43305. Int J Clin Pharmacol Ther. 2005. PMID: 16035372 Clinical Trial.
-
Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols.Eur J Clin Nutr. 2006 May;60(5):633-42. doi: 10.1038/sj.ejcn.1602362. Eur J Clin Nutr. 2006. PMID: 16404415 Clinical Trial.
-
Lowering LDL cholesterol with margarine containing plant stanol/sterol esters: is it still relevant in 2011?Complement Ther Med. 2011 Feb;19(1):37-46. doi: 10.1016/j.ctim.2010.12.004. Epub 2011 Jan 16. Complement Ther Med. 2011. PMID: 21296266 Review.
-
Comparable efficacy of hydrogenated versus nonhydrogenated plant sterol esters on circulating cholesterol levels in humans.Nutr Rev. 1998 Aug;56(8):245-8. doi: 10.1111/j.1753-4887.1998.tb01756.x. Nutr Rev. 1998. PMID: 9735678 Review.
Cited by
-
Serum and aortic levels of phytosterols in rabbits fed sitosterol or sitostanol ester preparations.Lipids. 2003 Nov;38(11):1115-8. doi: 10.1007/s11745-003-1168-8. Lipids. 2003. PMID: 14733355
-
Comparative health effects of margarines fortified with plant sterols and stanols on a rat model for hemorrhagic stroke.Lipids. 2003 Dec;38(12):1237-47. doi: 10.1007/s11745-003-1184-8. Lipids. 2003. PMID: 14870926
-
Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers (dietary portfolio) on circulating sterol levels and red cell fragility in hypercholesterolemic subjects.Lipids. 2005 Feb;40(2):169-74. doi: 10.1007/s11745-005-1372-6. Lipids. 2005. PMID: 15884765 Clinical Trial.
-
Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways.Curr Cardiol Rep. 2004 Nov;6(6):439-42. doi: 10.1007/s11886-004-0052-5. Curr Cardiol Rep. 2004. PMID: 15485605 Free PMC article. Review.
-
Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia.Drugs. 2002;62(16):2333-47. doi: 10.2165/00003495-200262160-00002. Drugs. 2002. PMID: 12396226 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical